- Home
- ESLA vs ONMD Comparison
ESLA vs ONMD Comparison
Compare ESLA & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- ONMD
- Stock Information
- Founded
- ESLA 2021
- ONMD 2006
- Country
- ESLA United States
- ONMD United States
- Employees
- ESLA N/A
- ONMD N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- ONMD
- Sector
- ESLA Health Care
- ONMD
- Exchange
- ESLA Nasdaq
- ONMD Nasdaq
- Market Cap
- ESLA 48.9M
- ONMD 43.5M
- IPO Year
- ESLA N/A
- ONMD N/A
- Fundamental
- Price
- ESLA $1.30
- ONMD $2.65
- Analyst Decision
- ESLA Strong Buy
- ONMD
- Analyst Count
- ESLA 1
- ONMD 0
- Target Price
- ESLA $16.00
- ONMD N/A
- AVG Volume (30 Days)
- ESLA 116.2K
- ONMD 15.3M
- Earning Date
- ESLA 11-20-2025
- ONMD 08-13-2025
- Dividend Yield
- ESLA N/A
- ONMD N/A
- EPS Growth
- ESLA N/A
- ONMD N/A
- EPS
- ESLA N/A
- ONMD N/A
- Revenue
- ESLA N/A
- ONMD $459,000.00
- Revenue This Year
- ESLA N/A
- ONMD N/A
- Revenue Next Year
- ESLA N/A
- ONMD N/A
- P/E Ratio
- ESLA N/A
- ONMD N/A
- Revenue Growth
- ESLA N/A
- ONMD N/A
- 52 Week Low
- ESLA $0.63
- ONMD $0.30
- 52 Week High
- ESLA $1.78
- ONMD $3.67
- Technical
- Relative Strength Index (RSI)
- ESLA 61.83
- ONMD 84.06
- Support Level
- ESLA $1.22
- ONMD $2.13
- Resistance Level
- ESLA $1.48
- ONMD $2.88
- Average True Range (ATR)
- ESLA 0.14
- ONMD 0.35
- MACD
- ESLA 0.01
- ONMD 0.18
- Stochastic Oscillator
- ESLA 56.82
- ONMD 66.04
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.